Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

[Pregnancy and breast cancer].

Ramírez-Torres N, Asbun-Bojalil J, Hernández-Valencia M.

Cir Cir. 2013 Mar-Apr;81(2):98-107. Spanish.

PMID:
23522309
2.

[Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].

Arce-Salinas C, Lara-Medina FU, Alvarado-Miranda A, Castañeda-Soto N, Bargalló-Rocha E, Ramírez-Ugalde MT, Pérez-Sánchez V, Rivera L, Gambo-Vignole C, Santamaría-Galicia J, Nieves-Casas RI, Morán-Muñoz H, Mohar-Betancourt A.

Rev Invest Clin. 2012 Jan-Feb;64(1):9-16. Spanish.

PMID:
22690524
3.

[Treatment of pregnancy associated breast cancer].

Székely B, Langmár Z, Somlai K, Szentmártoni G, Szalay K, Korompay A, Szász AM, Kulka J, Bánhidy F, Dank M.

Orv Hetil. 2010 Aug 8;151(32):1299-303. doi: 10.1556/OH.2010.28886. Hungarian.

PMID:
20656670
4.

[Study of 14 cases of breast cancer and pregnancy].

Vargas-Hernandez VM, Garcia-Rodriguez FM, Jiménez-Villanueva X, Hernandez-Rubio Á, Aboharp-Hassan Z, Moreno-Eutimio MA.

Cir Cir. 2013 Mar-Apr;81(2):108-11. Spanish.

PMID:
23522310
5.

Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Paija O, Helle L, Villman K, Nyandoto P, Nilsson G, Pajunen M, Asola R, Poikonen P, Leinonen M, Kataja V, Bono P, Lindman H.

J Clin Oncol. 2012 Jan 1;30(1):11-8. doi: 10.1200/JCO.2011.35.4639. Epub 2011 Nov 21.

PMID:
22105826
6.

Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.

Han W, Han MR, Kang JJ, Bae JY, Lee JH, Bae YJ, Lee JE, Shin HJ, Hwang KT, Hwang SE, Kim SW, Noh DY.

BMC Cancer. 2006 Apr 12;6:92.

7.
9.

Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.

Bai B, Yuan ZY, Liu DG, Teng XY, Wang SS.

Chin J Cancer. 2010 Apr;29(4):413-9.

10.

Chemotherapy and concomitant irradiation in inflammatory breast cancer.

Tubiana-Mathieu N, Lejeune C, Bonnier P, Genet D, Adjadj DJ, Berda JF, Muracciole X, Delaby F, Clavere P, Benyoub A, Rhein B, Juin B, Piana L.

Anticancer Res. 2001 Jul-Aug;21(4B):3061-7.

PMID:
11712811
11.

Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.

Michieletto S, Saibene T, Evangelista L, Barbazza F, Grigoletto R, Rossi G, Ghiotto C, Bozza F.

Breast. 2014 Feb;23(1):19-25. doi: 10.1016/j.breast.2013.10.001. Epub 2013 Nov 1.

PMID:
24189101
12.
13.

Multidisciplinary approach to breast cancer diagnosed during pregnancy: maternal and neonatal outcomes.

Córdoba O, Llurba E, Saura C, Rubio I, Ferrer Q, Cortés J, Xercavins J.

Breast. 2013 Aug;22(4):515-9. doi: 10.1016/j.breast.2012.10.005. Epub 2012 Oct 30.

PMID:
23116970
14.

Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

Bedognetti D, Sertoli MR, Pronzato P, Del Mastro L, Venturini M, Taveggia P, Zanardi E, Siffredi G, Pastorino S, Queirolo P, Gardin G, Wang E, Monzeglio C, Boccardo F, Bruzzi P.

J Natl Cancer Inst. 2011 Oct 19;103(20):1529-39. doi: 10.1093/jnci/djr351. Epub 2011 Sep 15.

15.

Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.

Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P, et al.

Clin Cancer Res. 1995 Feb;1(2):189-98.

16.

Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.

Calais G, Berger C, Descamps P, Chapet S, Reynaud-Bougnoux A, Body G, Bougnoux P, Lansac J, Le Floch O.

Cancer. 1994 Aug 15;74(4):1283-8.

17.

Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.

Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA.

J Clin Oncol. 2005 Jun 20;23(18):4192-7.

PMID:
15961766
18.

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.

Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P.

Br J Cancer. 2000 Dec;83(11):1480-7.

19.

[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].

Conti F, Carpano S, Sergi D, Di Lauro L, Amodio A, Vici P, Abbate MI, Ferranti FR, Viola G, Botti C, Foggi P, Sperduti I, Lopez M.

Clin Ter. 2007 Jul-Aug;158(4):331-41. Italian.

PMID:
17953285
20.

Treatment of breast cancer during pregnancy: an observational study.

Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, Fehm T, Van Calsteren K, Linn SC, Schlehe B, Gziri MM, Westenend PJ, Müller V, Heyns L, Rack B, Van Calster B, Harbeck N, Lenhard M, Halaska MJ, Kaufmann M, Nekljudova V, Amant F.

Lancet Oncol. 2012 Sep;13(9):887-96. doi: 10.1016/S1470-2045(12)70261-9. Epub 2012 Aug 16.

PMID:
22902483

Supplemental Content

Support Center